These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29567368)
1. Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies. Vigna E; Petrungaro A; Perri A; Terzi D; Recchia AG; Mendicino F; La Russa A; Bossio S; De Stefano L; Zinno F; Bonofiglio R; Morabito F; Gentile M Transfus Apher Sci; 2018 Apr; 57(2):247-249. PubMed ID: 29567368 [TBL] [Abstract][Full Text] [Related]
2. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Mannucci PM; Cugno M Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Congenital Thrombotic Thrombocytopenic Purpura With Eculizumab. Pecoraro C; Ferretti AV; Rurali E; Galbusera M; Noris M; Remuzzi G Am J Kidney Dis; 2015 Dec; 66(6):1067-70. PubMed ID: 26409664 [TBL] [Abstract][Full Text] [Related]
4. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP). Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904 [TBL] [Abstract][Full Text] [Related]
8. The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura. Rottenstreich A; Hochberg-Klein S; Rund D; Kalish Y J Thromb Thrombolysis; 2016 May; 41(4):678-83. PubMed ID: 26245827 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and novel treatment of thrombotic thrombocytopenic purpura]. Matsumoto M Rinsho Ketsueki; 2021; 62(5):480-485. PubMed ID: 34248125 [TBL] [Abstract][Full Text] [Related]
10. Syndromes of Thrombotic Microangiopathy. Shatzel JJ; Taylor JA Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review. Harambat J; Lamireau D; Delmas Y; Ryman A; Llanas B; Brissaud O Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343 [TBL] [Abstract][Full Text] [Related]
12. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment. Kameda T; Dobashi H; Kittaka K; Susaki K; Yamaoka G; Arai K; Tokuda M; Ishida T Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094 [TBL] [Abstract][Full Text] [Related]
13. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Coppo P; Veyradier A Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab. Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618 [TBL] [Abstract][Full Text] [Related]
15. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy]. Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956 [TBL] [Abstract][Full Text] [Related]
16. Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review. Liang SJ; Zheng QY; Li MS; Lv MY; Chen WT; Yang Y Clin Rheumatol; 2022 Aug; 41(8):2561-2569. PubMed ID: 35524885 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of rituximab in Japanese patients with acquired thrombotic thrombocytopenic purpura refractory to conventional therapy. Miyakawa Y; Imada K; Ichinohe T; Nishio K; Abe T; Murata M; Ueda Y; Fujimura Y; Matsumoto M; Okamoto S Int J Hematol; 2016 Aug; 104(2):228-35. PubMed ID: 27188338 [TBL] [Abstract][Full Text] [Related]
18. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M; Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]